Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $110.36 -0.8%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $10 billion versus the consensus estimate of $9.69 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- L3Harris CEO steps down amid conduct review, shares drop
- First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
